Tag: non-injectable insulin market share

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Non-injectable Insulin Market from 2024 to 2033?

The non-injectable insulin market is rapidly advancing, anticipated to grow from $1.71 billion in 2023 to $1.92 billion in 2024, with a CAGR of 12.2%. Key drivers include improvements in patient compliance, addressing needle phobia, enhancing quality of life, ease of use, and stable blood glucose control.

The non-injectable insulin market is projected to see rapid growth, reaching $2.89 billion in 2028 with a CAGR of 10.7%. Factors fueling this growth include a focus on patient compliance, solutions for needle phobia, quality of life improvements, enhanced safety, and reduced infection risks. Key trends include technological advancements, evolution of solutions, digital health integration, nanotechnology applications, and combination therapies.

Claim Your Free Sample of the Global Non-injectable Insulin Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13888&type=smp

What Key Factors Are Fueling the Growth of the Non-injectable Insulin Market?

The escalating issues of obesity and diabetes are projected to propel the growth of the non-injectable insulin market. Obesity is linked to excessive body fat, while diabetes is characterized by high blood sugar levels. Non-injectable insulin offers a convenient treatment option for managing these conditions. The World Heart Federation reported that global obesity rates are expected to rise from 2.3 billion in 2021 to 2.7 billion by 2025. Additionally, a report from the British Diabetic Association highlighted that 4.3 million individuals in the UK have diabetes. Consequently, these rising health concerns are fueling the non-injectable insulin market.

What Are the Major Segments of the Non-injectable Insulin Market?

1) By Type: Synthetic Insulin, Semi Synthetic Insulin

2) By Product: Pills, Sprays, Other Products

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Drug Stores

What New Trends Are Transforming the Non-injectable Insulin Market?

Companies in the non-injectable insulin market are advancing drug delivery technologies with needle-free oral insulin sprays. In November 2023, NiedlFree Technologies introduced Ozulin, a user-friendly oral insulin spray aimed at improving diabetes management.

Order Now for Fast Delivery of Your Non-injectable Insulin Market Report!

https://www.thebusinessresearchcompany.com/report/non-injectable-insulin-global-market-report

Which Regions Are Driving Growth in the Non-injectable Insulin Market?

North America was the largest region in the non-injectable insulin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-injectable insulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Non-injectable Insulin Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the non-injectable insulin market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Non-injectable Insulin Market Include

1. Non-injectable Insulin Market Executive Summary

2. Non-injectable Insulin Market Segments

3. Non-injectable Insulin Market Size And Template Market Growth Rate

4. Key Non-injectable Insulin Market Trends

5. Major Non-injectable Insulin Market Drivers

……

25. Key Mergers And Acquisitions In The Non-injectable Insulin Market

26. Top Non-injectable Insulin Companies

27. Non-injectable Insulin Market Opportunities And Strategies

28. Non-injectable Insulin Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-global-market-report

Insulin Patch Pumps Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-patch-pumps-global-market-report

Chemotherapy-Induced Nausea and Vomiting (CINV) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-nausea-and-vomiting-cinv-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Non-injectable Insulin Global Market Report 2024, the non-injectable insulin market is expected to show significant growth in the forecast period.

Expanding Non-Injectable Insulin Market Fueled By Escalating Obesity And Diabetes Epidemics

The non-injectable insulin market has witnessed rapid growth, driven by its expanding application in treating diabetes and obesity. In 2023, the market size reached $1.71 billion and is projected to grow to $1.92 billion in 2024, reflecting a compound annual growth rate (CAGR) of 12.2%. This growth is attributed to advancements enhancing patient compliance, addressing needle phobia, improving quality of life, easing administration, and stabilizing blood glucose levels.

Future Growth and Key Trends

The market is expected to continue its robust growth, reaching $2.89 billion by 2028, with a CAGR of 10.7%. Anticipated factors include sustained emphasis on patient compliance, ongoing solutions for needle phobia, further quality of life enhancements, improved safety profiles, and reduced risks of infection and injury. Key trends shaping this period include technological advancements, evolution of digital health integration, nanotechnology applications, and the rise of combination therapies.

View More On The Non-injectable Insulin Market Report 2024 – https://www.thebusinessresearchcompany.com/report/non-injectable-insulin-global-market-report

Innovative Advancements In Non-Injectable Insulin Delivery

Major companies are innovating in drug delivery technologies to enhance the management of diabetes. For example, needle-free oral insulin sprays offer a painless alternative for blood glucose regulation. NiedlFree Technologies introduced Ozulin, an oral insulin spray in November 2023, aiming to provide a user-friendly option for diabetes management. This innovation could revolutionize treatment by offering a convenient and pain-free alternative to traditional injections.

Abbott Expands Diabetes Care Portfolio With Acquisition Of Bigfoot Biomedical

In September 2023, Abbott Laboratories acquired Bigfoot Biomedical Inc., combining Abbott’s expertise in continuous glucose monitoring with Bigfoot’s smart insulin management systems. This acquisition reinforces Abbott’s leadership in comprehensive diabetes care, aligning with their commitment to advancing connected solutions for precise diabetes management.

Market Segmentation and Regional Insights

The non-injectable insulin market is segmented based on type (synthetic insulin, semi-synthetic insulin), product (pills, sprays, others), and distribution channel (hospital pharmacies, online pharmacies, drug stores). North America dominated the market in 2023, while Asia-Pacific is projected to be the fastest-growing region through the forecast period.

Conclusion

The non-injectable insulin market is expanding rapidly, driven by rising obesity and diabetes rates globally. Innovations in delivery technologies, such as oral insulin sprays, are enhancing treatment options and improving patient outcomes. With significant investments in technological advancements and strategic acquisitions, major companies are poised to capitalize on these opportunities, shaping the future landscape of diabetes management

Request A Sample Of The Global Non-injectable Insulin Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=13888&type=smp